For help on how to get the results you want, see our search tips.
1501 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): DuoTrav (updated)
travoprost, timolol, Glaucoma, Open-Angle, Ocular Hypertension
Date of authorisation: 23/04/2006, Revision: 17, Authorised, Last updated: 30/10/2020 -
List item
Human medicine European public assessment report (EPAR): Palynziq (updated)
Pegvaliase, Phenylketonurias
Date of authorisation: 03/05/2019,
, 
, Revision: 1, Authorised, Last updated: 30/10/2020
-
List item
Human medicine European public assessment report (EPAR): Ifirmacombi (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 04/03/2011,
, Revision: 11, Authorised, Last updated: 30/10/2020
-
List item
Human medicine European public assessment report (EPAR): Topotecan Hospira (updated)
topotecan, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 09/06/2010, Revision: 15, Authorised, Last updated: 30/10/2020 -
List item
Human medicine European public assessment report (EPAR): CoAprovel (updated)
irbesartan, hydrochlorothiazide, Hypertension
Date of authorisation: 14/10/1998, Revision: 40, Authorised, Last updated: 30/10/2020 -
List item
Human medicine European public assessment report (EPAR): Spravato (updated)
esketamine hydrochloride, Depressive Disorder
Date of authorisation: 18/12/2019,, Revision: 1, Authorised, Last updated: 29/10/2020
-
List item
Human medicine European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) (updated)
reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain, Influenza, Human
Date of authorisation: 20/05/2016,, 
, Revision: 6, Authorised, Last updated: 29/10/2020
-
List item
Human medicine European public assessment report (EPAR): Movymia (updated)
teriparatide, Osteoporosis
Date of authorisation: 11/01/2017,, 
, Revision: 7, Authorised, Last updated: 29/10/2020
-
List item
Human medicine European public assessment report (EPAR): Cinacalcet Mylan (updated)
cinacalcet hydrochloride, Hyperparathyroidism, Secondary, Hypercalcemia
Date of authorisation: 19/11/2015,, Revision: 8, Authorised, Last updated: 29/10/2020
-
List item
Human medicine European public assessment report (EPAR): Imraldi (updated)
adalimumab, Hidradenitis Suppurativa, Psoriasis, Crohn Disease, Uveitis, Arthritis, Rheumatoid, Arthritis, Colitis, Ulcerative, Spondylitis, Ankylosing, Arthritis, Psoriatic
Date of authorisation: 24/08/2017,, , Revision: 12, Authorised, Last updated: 29/10/2020
-
List item
Human medicine European public assessment report (EPAR): Jetrea (updated)
ocriplasmin, Retinal Diseases
Date of authorisation: 13/03/2013, Revision: 13, Authorised, Last updated: 29/10/2020 -
List item
Human medicine European public assessment report (EPAR): Hetlioz (updated)
tasimelteon, Sleep Disorders, Circadian Rhythm
Date of authorisation: 03/07/2015,, Revision: 6, Authorised, Last updated: 29/10/2020
-
List item
Human medicine European public assessment report (EPAR): Vepacel (updated)
Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 17/02/2012, Revision: 9, Withdrawn, Last updated: 28/10/2020 -
List item
Human medicine European public assessment report (EPAR): Docetaxel Kabi (updated)
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Breast Neoplasms
Date of authorisation: 22/05/2012,, Revision: 14, Authorised, Last updated: 28/10/2020
-
List item
Human medicine European public assessment report (EPAR): Terrosa (updated)
teriparatide, Osteoporosis
Date of authorisation: 04/01/2017,, , Revision: 4, Authorised, Last updated: 28/10/2020
-
List item
Human medicine European public assessment report (EPAR): Hefiya (updated)
adalimumab, Hidradenitis Suppurativa, Spondylitis, Ankylosing, Psoriasis, Arthritis, Juvenile Rheumatoid, Uveitis
Date of authorisation: 26/07/2018,, , Revision: 6, Authorised, Last updated: 28/10/2020
-
List item
Human medicine European public assessment report (EPAR): Lymphoseek (updated)
tilmanocept, Radionuclide Imaging
Date of authorisation: 19/11/2014, Revision: 7, Authorised, Last updated: 28/10/2020 -
List item
Human medicine European public assessment report (EPAR): Bronchitol (updated)
mannitol, Cystic Fibrosis
Date of authorisation: 13/04/2012,, Revision: 15, Authorised, Last updated: 28/10/2020
-
List item
Human medicine European public assessment report (EPAR): Docetaxel Accord (updated)
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Breast Neoplasms
Date of authorisation: 22/05/2012,, Revision: 14, Authorised, Last updated: 28/10/2020
-
List item
Human medicine European public assessment report (EPAR): Xalkori (updated)
crizotinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 23/10/2012, Revision: 28, Authorised, Last updated: 28/10/2020 -
List item
Human medicine European public assessment report (EPAR): Laventair Ellipta (previously Laventair) (updated)
umeclidinium bromide, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 08/05/2014,, Revision: 13, Authorised, Last updated: 28/10/2020
-
List item
Human medicine European public assessment report (EPAR): Pegasys (updated)
peginterferon alfa-2a, Hepatitis C, Chronic, Hepatitis B, Chronic
Date of authorisation: 20/06/2002, Revision: 39, Authorised, Last updated: 28/10/2020 -
List item
Human medicine European public assessment report (EPAR): Zynquista (updated)
Sotagliflozin, Diabetes Mellitus, Type 1
Date of authorisation: 26/04/2019,, Revision: 2, Authorised, Last updated: 27/10/2020
-
List item
Human medicine European public assessment report (EPAR): Protaphane (updated)
insulin human, Diabetes Mellitus
Date of authorisation: 07/10/2002, Revision: 18, Authorised, Last updated: 27/10/2020 -
List item
Human medicine European public assessment report (EPAR): Esperoct (updated)
Turoctocog alfa pegol, Hemophilia A
Date of authorisation: 20/06/2019,, Revision: 2, Authorised, Last updated: 27/10/2020